Jun 9, 2026 07:01AM
Jun 9, 2026 07:00AM
May 26, 2026 07:00AM
May 26, 2026 07:00AM
Apr 30, 2026 07:00AM
Mar 9, 2026 07:00AM
Jan 9, 2026 08:05AM Cartesian advances Descartes-08 trials across multiple autoimmune conditions
Jan 9, 2026 08:04AM
Nov 19, 2025 06:40AM
Nov 13, 2025 04:06PM
Nov 13, 2025 04:05PM
Nov 6, 2025 07:00AM
Oct 30, 2025 07:01AM
Oct 30, 2025 07:00AM Cartesian Therapeutics Announces Carsten Brunn, Ph.D., Named as Chairman of the Company’s Board of Directors
Aug 7, 2025 07:00AM
May 30, 2025 07:01AM
May 30, 2025 07:00AM
May 13, 2025 07:00AM
May 8, 2025 07:00AM
May 2, 2025 07:05AM
Apr 8, 2025 07:01AM Cartesian Therapeutics' (RNAC) Descartes-08 Observed to Provide Deep and Sustained Benefits Through Month 12 After a Single Course of Therapy in Phase 2b Myasthenia Gravis Trial
Apr 8, 2025 07:00AM
Apr 2, 2025 07:05AM
Apr 1, 2025 07:00AM
Mar 13, 2025 07:00AM
Jan 28, 2025 06:39AM
Jan 27, 2025 07:00AM
Jan 13, 2025 07:00AM Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune Diseases
Dec 3, 2024 06:01AM
Dec 3, 2024 06:00AM
Nov 21, 2024 07:00AM
Nov 7, 2024 07:00AM
Nov 5, 2024 09:00AM
Oct 15, 2024 07:03AM
Oct 15, 2024 07:00AM Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting
Sep 13, 2024 06:44AM
Sep 9, 2024 07:03AM
Sep 9, 2024 07:00AM
Sep 3, 2024 07:05AM
Sep 3, 2024 07:00AM
Aug 9, 2024 07:33AM
Aug 8, 2024 07:00AM Cartesian Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Jul 3, 2024 06:40AM
Jul 3, 2024 06:33AM
Jul 2, 2024 04:07PM
Jul 2, 2024 04:05PM
Jul 2, 2024 06:32AM
Jul 2, 2024 06:31AM
Jul 2, 2024 06:30AM Cartesian Therapeutics (RNAC) Reports Positive Topline Results from Phase 2b Trial of Descartes-08
Jul 2, 2024 06:30AM

323,582 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All